Publications
Publications 5076 - 5100 de 33557
Titre | DOI |
---|---|
Cardiovascular disease after treatment for Hodgkin's lymphoma: an analysis of nine collaborative EORTC-LYSA trials M.V. Maraldo; F. Giusti; I.R. Vogelius; M. Lundemann; M.A.E. van der Kaaij; S. Ramadan; B. Meulemans; M. Henry-Amar; B.M.P. Aleman; J. Raemaekers; P. Meijnders; E.C. Moser; H.C. Kluin-Nelemans; P. Feugier; O. Casasnovas; C. Fortpied; L. Specht; E.O.R.T.C.Lymphoma Grp 2015 |
10.1016/S2352-3026(15)00153-2 |
Cardiovascular disease in type 1 diabetes: A review of epidemiological data and underlying mechanisms B. Verges 2020 |
10.1016/j.diabet.2020.09.001 |
Cardiovascular effects of air pollution T. Bourdrel; M.A. Bind; Y. Bejot; O. Morel; J.F. Argacha 2017 |
10.1016/j.acvd.2017.05.003 |
Cardiovascular Effects of Etanercept in an Animal Model of Rheumatoid Arthritis: Mechanisms Involved P. Totoson; K. Maguin-Gate; A. Monnier; A. Tessier; C. Marie; F. Verhoeven; C. Prati; D. Wendling; C. Demougeot 2015 |
|
Cardiovascular Effects of Etanercept in an Animal Model of Rheumatoid Arthritis: Mechanisms Involved P. Totoson; K. Maguin-Gate; A. Monnier; A. Tessier; C. Marie; F. Verhoeven; C. Prati; D. Wendling; C. Demougeot 2015 |
|
Cardiovascular Effects of Etanercept in an Animal Model of Rheumatoid Arthritis: Mechanisms Involved P. Totoson; K. Maguin-Gate; A. Monnier; A. Tessier; C. Marie; F. Verhoeven; C. Prati; D. Wendling; C. Demougeot 2015 |
|
Cardiovascular imaging in Turner syndrome: state-of-the-art practice across the lifespan K.H. Mortensen; L. Young; J. De Backer; M. Silberbach; R.Thomas Collins; A.L. Duijnhouwer; B. Pandya; C.H. Gravholt; L. Lopez; J.W. Roos-Hesselink 2018 |
10.1136/heartjnl-2017-312658 |
Cardiovascular Mechanisms of Extravascular Lung Water Accumulation in Divers O. Castagna; E. Gempp; R. Poyet; B. Schmid; A.V. Desruelle; V. Crunel; A. Maurin; R. Choppard; D.H. MacIver 2017 |
10.1016/j.amjcard.2016.11.050 |
Cardiovascular outcomes after cardiac resynchronization therapy in cardiac amyloidosis K. Fischer; N. Lellouche; T. Damy; R. Martins; N. Clementy; A. Bisson; F. Lesaffre; M. Espinosa; R. Garcia; B. Degand; G. Serzian; F. Jourda; O. Huttin; J.B. Guichard; H. Devilliers; J.C. Eicher; G. Laurent; C. Guenancia 2022 |
10.1002/ehf2.13663 |
Cardiovascular prevention and at-risk behaviours in a large population of amateur rugby players F. Chague; M. Georges; A. Gudjoncik; T. Hermerel; G. Garet; J. Israel; J.P. Hager; P. Aviat; Y. Laurent; V. Gremeaux; Y. Cottin; M. Zeller 2019 |
10.1177/2047487319837066 |
Cardiovascular rehabilitation V. Gremeaux; J.M. Casillas 2017 |
10.1016/j.rehab.2016.12.001 |
Cardiovascular risk and stroke mortality in persons living with HIV: a longitudinal study in a hospital in Yaounde L.Mfeukeu Kuate; L.Ange Kwang Tchuisseu; A.Musa Jingi; C. Kouanfack; F.Teddy Endomba; C.Ngongang Ouankou; L. Ngarka; J.Jacques Noubiap; S. Kingue; A. Menanga; P.Ongolo Zogo 2021 |
10.11604/pamj.2021.40.8.30855 |
Cardiovascular Risk in COPD Deciphering the Contribution of Tobacco Smoking T. Soumagne; N. Roche; A. Guillien; M. Bouhaddi; S. Rocchi; S. Hue; F. Claude; L. Bizard; P. Andujar; J.C. Dalphin; B. Degano 2020 |
10.1016/j.chest.2019.11.002 |
Cardiovascular risk in psoriatic arthritis, a narrative review F. Verhoeven; C. Prati; C. Demougeot; D. Wendling 2020 |
10.1016/j.jbspin.2019.12.004 |
Cardiovascular risk profile of patients with peripheral arterial occlusive disease during nilotinib therapy E. Bondon-Guitton; S. Combret; M.C. Perault-Pochat; M. Steve-Dumont; H. Bagheri; F. Huguet; F. Despas; A. Pathak; J.L. Montastruc 2016 |
10.1007/s11523-016-0417-x |
Cardiovascular Surgical Emergencies in France, before, during and after the First Lockdown for COVID-19 in 2020: A Comparative Nationwide Retrospective Cohort Study A. Baudry; A.S. Mariet; E. Benzenine; V. Crespy; C. Bernard; M.C. Morgant; Y. Bejot; M. Giroud; O. Bouchot; E. Steinmetz; C. Quantin 2021 |
10.3390/life11111245 |
Cardioversion of atrial fibrillation in obese patients: Results from the Cardioversion-BMI randomized controlled trial A. Voskoboinik; J. Moskovitch; G. Plunkett; J. Bloom; G. Wong; C. Nalliah; S. Prabhu; H. Sugumar; R. Paramasweran; A. McLellan; L.H. Ling; C.Y. Goh; S. Noaman; H. Fernando; M. Wong; A.J. Taylor; J.M. Kalman; P.M. Kistler 2019 |
10.1111/jce.13786 |
Care management in a French cohort with Down syndrome from the AnDDI-Rares/CNSA study P.H. Roux-Levy; D. Sanlaville; B. De Freminville; R. Touraine; A. Masurel; I. Gueneau; A. Cotinaud-Ricou; S. Chancenotte; F. Debomy; D. Minot; M. Bournez; I. Rousseau; S. Daniel; E. Gautier; D. Lacombe; E. Taupiac; S. Odent; M. Mikaty; S. Manouvrier; J. Ghoumid; D. Genevieve; N. Lehman; T. Busa; C.P. Edery; J. Cornaton; J. Gallard; D. Heron; C. Rastel; C. Thauvin-Robinet; A. Verloes; C. Binquet; L. Faivre; C. Lejeune 2021 |
10.1016/j.ejmg.2021.104290 |
Care pathway of patients with metastatic pancreatic cancer in daily practice in France: Results from the REPERE national survey P. Hammel; R. Coriat; G. Lledo; M. de Bausset; M. Selosse; S. Obled; F. Bonnetain 2017 |
10.1016/j.bulcan.2016.11.022 |
CARFILZOMIB WEEKLY PLUS MELPHALAN AND PREDNISONE IN NEWLY DIAGNOSED ELDERLY MULTIPLE MYELOMA (IFM 2012-03) X. Leleu; G. Fouquet; L. Karlin; B. Kolb; M. Tiab; C. Araujo; N. Meuleman; T. de Revel; P. Bourquard; P. Lenain; M. Roussel; A. Jaccard; M.O. Petillon; K. Belhadj-Merzoug; G. Lepeu; M.L. Chretien; J. Fontan; P. Rodon; A. Schmitt; F. Offner; L. Voillat; S. Cerejat; F. Kuhnowsko; S. Rigaudeau; O. Decaux; C. Humbrecht-Kraut; J. Frayfer; O. Fitoussi; R. Weil; J.C. Eisenmann; V. Dorvaux; E.G. Voog; C. Hulin; M. Attal; P. Moreau; T. Facon 2016 |
|
CARFILZOMIB WEEKLY PLUS MELPHALAN AND PREDNISONE IN NEWLY DIAGNOSED ELDERLY MULTIPLE MYELOMA (IFM 2012-03) X. Leleu; G. Fouquet; L. Karlin; B. Kolb; M. Tiab; C. Araujo; N. Meuleman; T. de Revel; P. Bourquard; P. Lenain; M. Roussel; A. Jaccard; M.O. Petillon; K. Belhadj-Merzoug; G. Lepeu; M.L. Chretien; J. Fontan; P. Rodon; A. Schmitt; F. Offner; L. Voillat; S. Cerejat; F. Kuhnowsko; S. Rigaudeau; O. Decaux; C. Humbrecht-Kraut; J. Frayfer; O. Fitoussi; R. Weil; J.C. Eisenmann; V. Dorvaux; E.G. Voog; C. Hulin; M. Attal; P. Moreau; T. Facon 2016 |
|
Carfilzomib Weekly Plus Melphalan and Prednisone in Newly Diagnosed Elderly Multiple Myeloma (IFM 2012-03) X. Leleu; L. Karlin; B. Kolb; M. Tiab; C. Araujo; N. Meuleman; T. de Revel; P. Bourquard; P. Lenain; M. Roussel; A. Jaccard; M.O. Petillon; K. Belhadj-Merzoug; G. Lepeu; M.L. Chretien; J. Fontan; P. Rodon; A. Schmitt; F. Offner; L. Voillat; S. Cereja; F. Kuhnowski; S. Rigaudeau; O. Decaux; C. Humbrecht-Kraut; J. Frayfer; O. Fitoussi; D.Roos Weil; J.Claude Eisenmann; V. Dorvaux; E.G. Voog; C. Hulin; M. Attal; P. Moreau; T. Facon 2015 |
|
Carfilzomib Weekly Plus Melphalan and Prednisone in Newly Diagnosed Elderly Multiple Myeloma (IFM 2012-03) X. Leleu; G. Fouquet; L. Karlin; B. Kolb; M. Tiab; C. Araujo; P. Bourquard; P. Lenain; M. Roussel; A. Jaccard; M.O. Petillon; K. Belhadj-Merzoug; G. Lepeu; M.L. Chretien; J. Fontan; P. Rodon; A. Schmitt; L. Voillat; S. Cereja; F. Kuhnowski; S. Rigaudeau; O. Decaux; J. Frayfer; O. Fitoussi; D.Roos Weil; J.C. Eisenmann; V. Dorvaux; E. Voog; C. Hulin; M. Attal 2017 |
10.1016/j.clml.2017.03.013 |
Carfilzomib Weekly plus Melphalan and Prednisone in Newly Diagnosed Transplant-Ineligible Multiple Myeloma (IFM 2012-03): A Phase I Trial X. Leleu; G. Fouquet; V. Richez; S. Guidez; A. Duhamel; F. Machuron; L. Karlin; B. Kolb; M. Tiab; C. Araujo; N. Meuleman; J.V. Malfuson; P. Bourquard; P. Lenain; M. Roussel; A. Jaccard; M.O. Petillon; K. Belhadj-Merzoug; G. Lepeu; M.L. Chretien; J. Fontan; P. Rodon; A. Schmitt; F. Offner; L. Voillat; S. Cereja; F. Kuhnowski; S. Rigaudeau; O. Decaux; C. Humbrecht-Kraut; J. Frayfer; O. Fitoussi; D. Roos-Weil; J.C. Eisenmann; V. Dorvaux; E.G. Voog; M. Attal; P. Moreau; H. Avet-Loiseau; C. Hulin; T. Facon 2019 |
10.1158/1078-0432.CCR-18-3642 |
Cargo-free particles of ammonio methacrylate copolymers: From pharmaceutical inactive ingredients to effective anticancer immunotherapeutics M.Alsadat Sh Boushehri; V. Stein; A. Lamprecht 2018 |
10.1016/j.biomaterials.2018.02.053 |